Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Understanding the benefits of compounding in investing can greatly enhance your financial strategy. Discover how it can multiply your returns.
14,685 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Two popular small-cap growth ETFs—ISCG and RZG—take different paths to growth. This guide breaks down how they work, ...
A hotter-than-expected inflation reading this week could push the Fed toward another rate hike, according to Fed Gove...
GE Vernova arrives at its July 22 earnings with a $163 billion backlog and raised targets, signaling a strong beat ri...
JPMorgan Chase delivered a record quarterly performance, yet Jamie Dimon cautioned that the current market sprint cou...
EU DAC8 and UK CARF rules are now driving tax reporting for 2027. As providers capture 2026 activity, investors shoul...
As Netflix prepares for its July 16 report, a developing narrative about live channels could be a pivotal signal for ...
When big builders cut prices to move inventory, investors win—if they know how to structure deals. This guide breaks ...
Lucid Group sparked a sharp rally after the CEO denied bankruptcy rumors and take-private chatter. This article break...
A major VC consortium has backed Suno in a round valuing the AI music platform at $5.4 billion, a move critics say hi...
Jim Cramer tells CNBC’s Mad Money Investing Club to sell Oracle and avoid liquor stocks, outlining a mix of defensive...
Taiwan Semiconductor is in the spotlight as it signals higher capital spending. This article breaks down whether tsmc...